Chinese biopharma firm Abbisko closes $70m Series C round led by Temasek

Chinese biopharma firm Abbisko closes $70m Series C round led by Temasek

Source: Laurynas Mereckas/Unsplash

Shanghai-based Abbisko Therapeutics has secured $70 million in a Series C round of financing led by Singaporean state-owned investment firm Temasek, bringing the total capital raised by the Chinese biopharma firm to $140 million.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter